Great Lakes Advisors LLC Takes $2.52 Million Position in Bath & Body Works, Inc. $BBWI

Great Lakes Advisors LLC purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWIFree Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 108,755 shares of the company’s stock, valued at approximately $2,516,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Global Retirement Partners LLC acquired a new position in Bath & Body Works during the fourth quarter worth about $31,000. Activest Wealth Management bought a new position in Bath & Body Works during the fourth quarter worth $32,000. Geneos Wealth Management Inc. increased its holdings in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the last quarter. Finally, Danske Bank A S purchased a new stake in Bath & Body Works in the 3rd quarter valued at $39,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $19.47 on Friday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The company has a market cap of $3.92 billion, a P/E ratio of 5.47, a PEG ratio of 1.94 and a beta of 1.38. The stock’s fifty day moving average price is $20.47 and its 200-day moving average price is $20.10.

Bath & Body Works (NYSE:BBWIGet Free Report) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date is Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. TD Cowen raised their target price on Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company lifted their target price on Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Finally, UBS Group restated a “neutral” rating on shares of Bath & Body Works in a report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $22.57.

Get Our Latest Research Report on BBWI

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Further Reading

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.